Impedimed device gets breakthrough designation for kidney failure
The company’s bioimpedance spectroscopy device would be used to measure how much fluid should be removed from a patient during dialysis.
Cricket Health locks in $24M to expand its footprint in the kidney care space
The startup, which leverages technology to assist chronic kidney disease and end-stage renal disease patients, has wrapped up a $24 million Series A round led by Oak HC/FT.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
Study highlights how EHR data can pinpoint undiagnosed genetic diseases
The study out of Vanderbilt University Medical Center found 14 percent of individuals with genetic variants impacting the kidney had kidney transplants and 10 percent with another variant had liver transplants. These transplants could have been avoided had the underlying genetic cause been disclosed.
Dialysis on demand: Outset Medical raises $60M for simple at-home device that treats kidney failure
Outset Medical just raised $60 million - and possibly more - to build out its at-home dialysis machine for patients with kidney failure.